Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma
, , , , , , , et
03 déc. 2020
À propos de cet article
Catégorie d'article: Research Article
Publié en ligne: 03 déc. 2020
Pages: 66 - 76
Reçu: 21 juil. 2020
Accepté: 06 oct. 2020
DOI: https://doi.org/10.2478/raon-2020-0070
Mots clés
© 2021 Cuimeng Tian, Guimei Liu, Yongxiang Xu, Guangrong Xia, Tongmei Zhang, Jiaqiang Huang, Hui Jiang, Ji Ming Wang, Baolan Li, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Tian, Cuimeng
Department of Radiation Oncology, Beijing Tuberculosis and Thoracic Tumor Research Institute / Beijing Chest Hospital, Capital Medical UniversityBeijing, China
Laboratory of Cancer ImmunoMetabolism, Center for Cancer Research, National Cancer Institute at FrederickFrederick, USA
Liu, Guimei
Department of Radiation Oncology, Beijing Tuberculosis and Thoracic Tumor Research Institute / Beijing Chest Hospital, Capital Medical UniversityBeijing, China
Xu, Yongxiang
Department of Radiation Oncology, Beijing Tuberculosis and Thoracic Tumor Research Institute / Beijing Chest Hospital, Capital Medical UniversityBeijing, China
Xia, Guangrong
Department of Radiation Oncology, Beijing Tuberculosis and Thoracic Tumor Research Institute / Beijing Chest Hospital, Capital Medical UniversityBeijing, China
Zhang, Tongmei
Department of General Medicine, Beijing Tuberculosis and Thoracic Tumor Research Institute / Beijing Chest Hospital, Capital Medical UniversityBeijing, China
Huang, Jiaqiang
Department of Cellular and Molecular Biology, Beijing Tuberculosis and Thoracic Tumor Research Institute / Beijing Chest Hospital, Capital Medical UniversityBeijing, China
Jiang, Hui
Division of Technology, Beijing Tuberculosis and Thoracic Tumor Research Institute / Beijing Chest Hospital, Capital Medical UniversityBeijing, China
Ming Wang, Ji
Laboratory of Cancer ImmunoMetabolism, Center for Cancer Research, National Cancer Institute at FrederickFrederick, USA
Li, Baolan
Department of General Medicine, Beijing Tuberculosis and Thoracic Tumor Research Institute / Beijing Chest Hospital, Capital Medical UniversityBeijing, China